Consolidated Statements of Cash Flows - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net loss		$ (296.0)	$ (169.1)
Loss from discontinued operations, net of tax		(35.2)	(6.5)
Loss from continuing operations, net of tax		(260.8)	(162.6)
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:
Depreciation		31.5	39.6
Amortization		15.1	17.6
Provision for doubtful accounts		39.6	48.5
Provision for obsolescence		20.5	20.3
Share-based compensation		5.0	7.7
Foreign exchange (gains) losses		6.0	(1.2)
Deferred income taxes		3.3	(10.5)
Costs associated with debt issue / repayment		15.0	0.0
Impairment loss on assets		0.0	1.0
Gain on sale of business / assets			(8.3)
Other		4.1	(0.9)
Changes in assets and liabilities:
Accounts receivable		(57.4)	(51.2)
Inventories		(51.5)	(76.4)
Prepaid expenses and other		(4.3)	6.1
Accounts payable and accrued liabilities		(10.6)	(80.9)
Income and other taxes		10.5	(8.8)
Noncurrent assets and liabilities		11.0	(38.2)
Net cash used by operating activities of continuing operations		(223.0)	(298.2)
Cash Flows from Investing Activities
Capital expenditures		(40.5)	(48.2)
Disposal of assets		3.4	2.3
Net proceeds from sale of business / assets		0.0	13.9
Net cash used by investing activities of continuing operations	[1]	(37.1)	(32.0)
Cash Flows from Financing Activities
Debt, net (maturities of three months or less)		135.0	(5.0)
Proceeds from debt from affiliates of Natura & Co		863.5	269.9
Repayment of debt		(733.2)	(57.5)
Repayment of debt to affiliates of Natura &Co		(52.8)	(31.7)
Repayment of debt by affiliates of Natura &Co		40.6	49.8
Costs associated with debt issue / repayment		(15.0)	0.0
Settlement of derivative contracts		12.0	(3.9)
Repayment of monetization of COFINS tax credits		0.0	(15.5)
Net cash provided by financing activities of continuing operations	[1]	250.1	206.1
Net cash used by operating activities of discontinued operations		(20.0)	(7.5)
Net cash used by discontinued operations		(20.0)	(7.5)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash		(4.8)	(16.5)
Net decrease in cash and cash equivalents, and restricted cash		(34.8)	(148.1)
Cash and cash equivalents, and restricted cash at beginning of period		251.5	373.4
Cash and cash equivalents, and restricted cash at end of period		$ 216.7	$ 225.3

[1] (1) On July 1, 2021, the Company sold Avon Luxembourg Holdings S.à.r.l. ("Avon Luxembourg"), including our Mexican business, to a subsidiary of Natura &Co Holding for $150, with the proceeds used to repay maturing loans of $150 borrowed under the Natura Revolving Credit Facility (as defined in Note 15 Debt). Under the terms of the transaction and the associated Direction and Settlement Agreement, no cash flows in either investing or financing activities arose as a result of the transaction.